Webinar: Issues in Product Characterization

April 15, 2010

Webinar Overview

CIRM hosted this webinar as the sponsor of the Regenerative Medicine Consortium’s (RMC’s) webinar series on IND readiness. The mission of the RMC is to accelerate the development and regulatory approval of stem cell and regenerative medicine therapies. For more information please see
http://www.cirm.ca.gov/RegenerativeMedicineConsortium.

Webinar Topic & Agenda

Key Issues in Product Characterization

Moderator: Elona Baum, General Counsel, CIRM and RMC Chair

Speakers - Slides

• Mahendra Rao, Ph.D., Life Technologies, Vice President of Stem Cell Research See the slides [pdf]
• Scott R. Burger, M.D., Advanced Cell and Gene Therapy See the slides [pdf]
• Donald W. Fink, Jr., Ph.D., Cell Therapy Branch, Division of Cellular and Gene Therapies, Office of Cellular, Tissue, and Gene Therapies, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration See the slides [pdf]

Videos

• Introduction by Elona Baum
• Webinar session
   

Q&A Session

• Q&A document [pdf]